ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · IEX Real-Time Price · USD
0.898
+0.063 (7.54%)
Jul 22, 2024, 10:26 AM EDT - Market open
ImmunoPrecise Antibodies Employees
ImmunoPrecise Antibodies had 102 employees as of April 30, 2023. The number of employees increased by 17 or 20.00% compared to the previous year.
Employees
102
Change (1Y)
17
Growth (1Y)
20.00%
Revenue / Employee
$173,251
Profits / Employee
-$104,302
Market Cap
22.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2023 | 102 | 17 | 20.00% |
| Apr 30, 2022 | 85 | 12 | 16.44% |
| Apr 30, 2021 | 73 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ekso Bionics Holdings | 72 |
| Inspira Technologies Oxy B.H.N. | 42 |
| Sol-Gel Technologies | 36 |
| Gain Therapeutics | 32 |
| Nephros | 31 |
| OneMedNet | 20 |
| Minerva Neurosciences | 9 |
| Aprea Therapeutics | 7 |
IPA News
- 5 days ago - ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures - Business Wire
- 7 days ago - IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024 - Business Wire
- 25 days ago - ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer - Business Wire
- 27 days ago - IPA's Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™ - Business Wire
- 5 weeks ago - ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology - Business Wire
- 6 weeks ago - BioStrand, ImmunoPrecise Antibodies' Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery - Business Wire
- 6 weeks ago - IPA's Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR) - Business Wire
- 3 months ago - Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results - Accesswire